hVIVO plc (LON:HVO – Get Free Report) was down 6.8% on Thursday . The stock traded as low as GBX 19 ($0.24) and last traded at GBX 19.10 ($0.24). Approximately 2,518,262 shares traded hands during trading, a decline of 26% from the average daily volume of 3,389,765 shares. The stock had previously closed at GBX 20.50 ($0.26).
hVIVO Trading Down 6.8 %
The stock has a market capitalization of £129.95 million, a PE ratio of 636.67 and a beta of 0.97. The company has a current ratio of 1.61, a quick ratio of 1.16 and a debt-to-equity ratio of 33.86. The stock has a 50 day moving average price of GBX 23.58 and a 200-day moving average price of GBX 26.77.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Featured Articles
- Five stocks we like better than hVIVO
- What Makes a Stock a Good Dividend Stock?
- 3 Legacy Tech Companies Reemerging as AI Leaders
- What is the Euro STOXX 50 Index?
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- Trading Halts Explained
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
